| Primary |
| Depression |
36.0% |
| Bipolar Disorder |
12.0% |
| Emphysema |
12.0% |
| Product Used For Unknown Indication |
12.0% |
| Drug Use For Unknown Indication |
8.0% |
| Arrhythmia |
4.0% |
| Atrial Fibrillation |
4.0% |
| Cardiac Failure Chronic |
4.0% |
| Cardiac Failure Congestive |
4.0% |
| Pneumonia |
4.0% |
|
| Blepharospasm |
20.0% |
| Blood Potassium Increased |
20.0% |
| Neuroleptic Malignant Syndrome |
20.0% |
| Thirst |
20.0% |
| Ventricular Extrasystoles |
20.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
21.3% |
| Depression |
16.2% |
| Product Used For Unknown Indication |
15.3% |
| Schizophrenia |
8.8% |
| Insomnia |
7.5% |
| Depressed Mood |
4.5% |
| Depressive Symptom |
3.4% |
| Fatigue |
3.0% |
| Mood Altered |
2.7% |
| Emphysema |
2.4% |
| Hypertension |
2.1% |
| Atrial Fibrillation |
1.9% |
| Ill-defined Disorder |
1.7% |
| Psychotic Disorder |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Anxiety |
1.5% |
| Abnormal Behaviour |
1.2% |
| Major Depression |
1.2% |
| Anxiety Disorder |
1.1% |
| Disturbance In Attention |
1.0% |
|
| Neuroleptic Malignant Syndrome |
14.3% |
| Suicide Attempt |
11.6% |
| Dementia |
10.7% |
| Parkinsonism |
8.9% |
| Tonic Convulsion |
6.3% |
| Restlessness |
5.4% |
| Rhabdomyolysis |
5.4% |
| Serotonin Syndrome |
5.4% |
| Faecaloma |
3.6% |
| Blepharospasm |
2.7% |
| Galactorrhoea |
2.7% |
| Hepatic Function Abnormal |
2.7% |
| Muscular Weakness |
2.7% |
| Pneumonia |
2.7% |
| Quadriplegia |
2.7% |
| Toxic Skin Eruption |
2.7% |
| Urinary Incontinence |
2.7% |
| Ventricular Tachycardia |
2.7% |
| Weight Increased |
2.7% |
| Coma |
1.8% |
|
| Concomitant |
| Depression |
22.3% |
| Schizophrenia |
14.4% |
| Drug Use For Unknown Indication |
10.0% |
| Hypertension |
8.3% |
| Product Used For Unknown Indication |
6.6% |
| Rheumatoid Arthritis |
6.2% |
| Insomnia |
5.9% |
| Breast Cancer |
3.1% |
| Prophylaxis |
2.7% |
| Psychotic Disorder |
2.4% |
| Hiv Infection |
2.2% |
| Constipation |
2.1% |
| Hepatitis C |
2.1% |
| Anxiety |
1.9% |
| Pain |
1.8% |
| Bipolar Disorder |
1.8% |
| Gastritis |
1.7% |
| Headache |
1.6% |
| Epilepsy |
1.5% |
| Dementia |
1.4% |
|
| Weight Decreased |
10.4% |
| White Blood Cell Count Increased |
8.8% |
| Vomiting |
8.1% |
| Tremor |
7.8% |
| White Blood Cell Count Decreased |
7.2% |
| Suicidal Ideation |
6.8% |
| Pyrexia |
5.2% |
| Liver Disorder |
4.9% |
| Pneumonia |
4.6% |
| Cerebral Infarction |
4.2% |
| Malaise |
3.9% |
| Somnolence |
3.9% |
| Weight Increased |
3.6% |
| Psychotic Disorder |
3.3% |
| Renal Failure Acute |
3.3% |
| Rhabdomyolysis |
2.9% |
| Urinary Tract Infection |
2.9% |
| Urine Output Increased |
2.9% |
| Drug Interaction |
2.6% |
| Interstitial Lung Disease |
2.6% |
|
| Interacting |
| Schizophrenia |
50.0% |
| Schizophrenia, Paranoid Type |
33.3% |
| Product Used For Unknown Indication |
16.7% |
|
| Completed Suicide |
40.0% |
| Hyperprolactinaemia |
20.0% |
| Loss Of Consciousness |
20.0% |
| Tremor |
20.0% |
|
